NEW YORK – The European Unified Patent Court (UPC) on Tuesday issued a preliminary injunction against Curio Bioscience in a patent infringement case brought by 10x Genomics that will prevent Curio from doing business in France, Germany, and Sweden.

纽约——周二，欧洲联合专利法院（UPC）在10x Genomics提起的专利侵权案中，对古董生物科学发出了初步禁令，这将阻止古董在法国、德国和瑞典开展业务。

In its order, the UPC Local Division in Düsseldorf, Germany, found that Curio's Seeker spatial biology platform likely infringes claim 14 of European Patent No. 2,697,391, held by 10x Genomics. The claim protects 'an array for use in the localized detection of nucleic acid in a tissue sample comprising cells.' The court ordered Curio 'not to offer any product that would violate' that claim in those countries.

UPC在德国杜塞尔多夫的地方部门在其命令中发现，古玩的探索者空间生物学平台可能侵犯了10x Genomics持有的欧洲专利号2697391的权利要求14。该权利要求保护“用于在包含细胞的组织样品中定位检测核酸的阵列”法院命令古玩“不要在这些国家提供任何违反”这一主张的产品。

.

.

The court also said that it could not establish indirect infringement of claim 1 of the patent by Curio, as alleged by 10x.

法院还表示，它不能证明古玩（Curio）间接侵犯该专利的权利要求1，正如10x所声称的那样。

In a statement, Curio said it considered the order a 'win,' noting that claim 1 was 'the broadest and main spatial transcriptomics claim of the '391 patent' while claim 14 is 'narrow in scope and has no effect on Curio's business.' Curio said it 'will comply with the order and expects no impact to its commercial business,' adding that the ruling 'is restricted to the three countries mentioned and does not affect Curio's activities elsewhere, nor does it impact other Curio products.' .

Curio在一份声明中表示，它认为该订单是“胜利”，并指出权利要求1是“391专利”中最广泛和主要的空间转录组学权利要求，而权利要求14“范围狭窄，对Curio的业务没有影响”古玩公司表示，将遵守该命令，预计不会对其商业业务产生影响，并补充说，该裁决“仅限于上述三个国家，不会影响古玩在其他地方的活动，也不会影响其他古玩产品。”。

'We are pleased with the UPC's decision, which helps protect our continued investments in innovation for the scientific community,' a 10x spokesperson said in an email.

“我们对UPC的决定感到高兴，这有助于保护我们对科学界创新的持续投资，”10x发言人在一封电子邮件中说。

10x has sued Curio in the US and in Europe alleging infringement of several of its patents. In the UPC, 10x is alleging infringement of IP acquired when it bought Spatial Transcriptomics, a spinout of Sweden's SciLifeLab.

10x已在美国和欧洲起诉Curio，指控其多项专利受到侵犯。在UPC中，10x指控其收购瑞典SciLifeLab的衍生产品Spatial Transcriptomics时获得的知识产权受到侵犯。

Curio's Seeker platform is based on the Slide-seq spatial transcriptomics method developed by the Broad Institute's Fei Chen and Evan Macosko. The firm is based in Palo Alto, California.

Curio的Seeker平台基于Broad Institute的Fei Chen和Evan Macosko开发的Slide-seq空间转录组学方法。该公司总部位于加利福尼亚州帕洛阿尔托。

If Curio is found to have contravened the order, it faces a penalty of €100,000 ($106,861) per day.

如果发现古玩违反了这项命令，它将面临每天100000欧元（106861美元）的罚款。

The court noted that the order is enforceable, but only once 10x 'has provided security in favor of [Curio] in the form of a deposit or bank guarantee in the amount of €2 million.'

法院指出，这项命令是可执行的，但只有在10x“以200万欧元的存款或银行担保的形式为[古董]提供了担保之后。”